Navigation Links
Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma
Date:12/8/2008

45,000 deaths annually.

About VELCADE

VELCADE is co-developed by Millennium Pharmaceuticals, Inc. and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Millennium is responsible for commercialization of VELCADE in the U.S., Janssen-Cilag is responsible for commercialization in Europe and the rest of the world. Janssen Pharmaceutical K.K. is responsible for commercialization in Japan. VELCADE is approved in more than 87 countries worldwide.

Important Safety Information

In the U.S., VELCADE is indicated for the treatment of patients with multiple myeloma. VELCADE also is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron or mannitol. VELCADE should be administered under the supervision of a physician experienced in the use of antineoplastic therapy.

Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary disorders, reversible posterior leukoencephalopathy syndrome, gastrointestinal adverse events, thrombocytopenia, neutropenia, tumor lysis syndrome and hepatic events. Women of childbearing potential should avoid becoming pregnant while being treated with VELCADE. Nursing mothers are advised not to breastfeed while receiving VELCADE. Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell lymphoma. Acute development or exacerbation of congestive heart failure, and new onset of decreased left ventricular ejection fraction has been reported, including reports in patients with no risk factors for decreased left ventricular ejection fraction. There have been reports of acute diffuse infiltrative pulmonary disease of unknown
'/>"/>

SOURCE Millennium: The Takeda Oncology Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
2. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
3. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
4. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
5. Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
6. New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
7. Continued Funding to Help Advance Exciting Moment in Diabetes Research
8. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
9. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
10. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
11. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...linker.comannouncesthatanewmarketresearchreportisa...s&Equipment-AGlobalMarketPerspective ,, ...-Systems--Equipment---A-Global-Market-Perspective....tm_campaign=prnewswire ,, Steamsterilizatio...re.Steamsterilizationmarketisstableduetoregulatory...
(Date:11/23/2009)...linker.comannouncesthatanewmarketresearchreportisa...es-AWorldMarketReview ,, http://www.reportli...-Market-Review.html#utm_source=prnewswire&utm_...obalgeneralanesthesiadisposablesmarketischaracteri...erisewitnessedingeneralsurgicalprocedures,growingp...
(Date:11/23/2009)...-LightSciencesOncology,Inc.(LSO)todayannouncedthee...anewlycreatedseatonitsboardofdirectors.Mr.Seddighi...nies,includingElekta,tomarketleadership. ,, "Th...inbusinessdevelopmenttotheboard,"saidLSO,sChairman...ancer-therapybusinessdevelopment.Hehasoverseenthee...
Breaking Medicine Technology:Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Eisai Donates More Than 80 Murals to Hospitals Around the United States 61147 1Eisai Donates More Than 80 Murals to Hospitals Around the United States 61147 2Eisai Donates More Than 80 Murals to Hospitals Around the United States 61147 3Clinical Resourcing Firm ASG Changes Name to Ockham 61144 1OTCBB WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners 61141 1OTCBB WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners 61141 2OTCBB WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners 61141 3
...iences announced,today the successful acquisition ...and Infectious Disease (NIAID/NIH) to support the ...al microbicides to prevent the sexual,transmission...search (SBIR),grant provides funding for the conti...e molecules which effectively inhibit two critical...
... Timothy Mastro,MD, FACP, DTM&H, who joins Family ... Director of Research, will share information on p...rEP) for HIV prevention at the,International AIDS ...tion, titled "Pre-Exposure Prophylaxis: Current,an...ng clinical trials that,suggest oral doses of cert...
Other Medicine Technology:ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide 2HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference 2
(Date:11/23/2009)...geofMedicalGenetics(ACMG)EncouragesFamiliestoGathe...toryDay,Thanksgiving2009 ,, BETHESDA,Md.,Nov.2...thannualNationalFamilyHistoryDay,asdeclaredbytheU....cs(ACMG)encourageseveryonetoknowtheirfamilymedical...llylife-savinginformation,to"starttheconversation"...
(Date:11/23/2009)...v.23/PRNewswire-FirstCall/--InfoLogix,Inc.(Nasdaq:...litysolutionsforthehealthcareandcommercialindustri...anagedServicesatSiemensHealthServices,hasjoinedInf.... ,, (Logo: http://www.newscom.com/cgi-bin/prnh...ategicHealthcareServicesforInfoLogix,Mr.Waywillber...
(Date:11/23/2009)...senic compounds appears to cause oxidative DNA dam...ng to a new study published online November 23 in ... Although biomethylation was once believed to det...nce its toxicity and potentially its carcinogenici...tion in oxidative DNA damage in mice, Michael P. W...
(Date:11/23/2009)...th care professionals enjoy a pay raise for a job ...ives for health care performance may actually back...are performance ratings for 25 medical groups acro... launch of a statewide pay-for-performance program...rs, productivity. , Reporting in the December...
(Date:11/23/2009)...rs getting chemo deal with insomnia, study shows ,...nsomnia and sleep disorders affect more than three...py, a rate nearly three times higher than that of ...e problem is more common in younger patients and i...ity of Rochester Medical Center researchers, who a...
Breaking Medicine News(10 mins):Health News:'Family Health History and Genetics Privacy' is the Newest Addition to the ACMG Genetics & Your Health Video Series 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3
...hat taking selenium supplements may, over time, ma..., published in the Annals of Internal Medicine's a... supplements cause type 2 diabetes, however, the r...rally occurring trace mineral present in soil and ...
...th six British universities have concluded that fo...ate change in the future . According to ex...ty of Swansea; the Open University; the University...ingdom is not as stable as was previously thought....
...n Antarctica switched from eating fish to krill (s... time that humans began hunting seals and whales,...ding to Steven Emslie of the University of North C...rs, the penguins exploited the resulting shrimp su...
...l their amorous intentions by exchanging bursts of... Scientists describe this behavior as being so.... According to the study, which has been r...f electric fish was largely a private matter, clai...
...t to introduce sex education in its schools from C...ooks , saying the material goes against Indian cul... by the government should be promptly withdrawn," ...be compelled to make a bonfire of these books in p...
...ffluent Singapore have surged to their highest lev...al figures showed Tuesday . Health ministr...k, the second week in a row that the number of cas... National Environment Agency said in a joint state...
Other Medicine News:Health News:Selenium Supplements may Increase Type 2 Diabetes Risk 2Health News:Fossilized Midges can Predict Climate Change: Study 2Health News:Penguins Altered Diet When Humans Began Hunting Whales and Seals 2Health News:Amorous African Fish Exchange Electric Pulses While Mating 2
...you to,change the way you work,OrthoPad is th...signed to fit into,your existing orthopaedic,w...o,enhance overall productivity,in the orthopae...tients in the same,amount of time.We know,that...
Tag-It Cystic Fibrosis PCR Mix
Shandon Paraffin Block Cartons
Flash-Mini™
Medicine Products: